A Clinical Trial Failure Derails a Promising Technology

Neal Sondheimer, outgoing head of clinical for Synlogic and adjunct associate professor of pediatrics and molecular genetics for The Hospital for Sick Children in Toronto, discusses PKU, the treatment options for people with the condition, and the consequences of the surprising results from the Synlogic study.